LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Barasertib | 3.33 | uM | LJP5 | 1 | D08 | 72 | hr | 1311 | 1575 | 5128 | 0.3071 | 0.0975 |
MDA-MB-231 | Barasertib | 3.33 | uM | LJP5 | 2 | D08 | 72 | hr | 1311 | 1758 | 5100 | 0.3447 | 0.1612 |
MDA-MB-231 | Barasertib | 3.33 | uM | LJP5 | 3 | D08 | 72 | hr | 1311 | 1490 | 5010 | 0.2974 | 0.0681 |
MDA-MB-231 | Barasertib | 10 | uM | LJP5 | 1 | D07 | 72 | hr | 1311 | 1581 | 5128 | 0.3083 | 0.0996 |
MDA-MB-231 | Barasertib | 10 | uM | LJP5 | 2 | D07 | 72 | hr | 1311 | 1504 | 5100 | 0.2949 | 0.0723 |
MDA-MB-231 | Barasertib | 10 | uM | LJP5 | 3 | D07 | 72 | hr | 1311 | 1438 | 5010 | 0.2870 | 0.0487 |
MDA-MB-231 | Vemurafenib | 0.04 | uM | LJP5 | 1 | C18 | 72 | hr | 1311 | 4827 | 5128 | 0.9412 | 0.9394 |
MDA-MB-231 | Vemurafenib | 0.04 | uM | LJP5 | 2 | C18 | 72 | hr | 1311 | 4973 | 5100 | 0.9751 | 0.9744 |
MDA-MB-231 | Vemurafenib | 0.04 | uM | LJP5 | 3 | C18 | 72 | hr | 1311 | 4742 | 5010 | 0.9464 | 0.9438 |
MDA-MB-231 | Vemurafenib | 0.12 | uM | LJP5 | 1 | C17 | 72 | hr | 1311 | 4799 | 5128 | 0.9358 | 0.9336 |
MDA-MB-231 | Vemurafenib | 0.12 | uM | LJP5 | 2 | C17 | 72 | hr | 1311 | 4899 | 5100 | 0.9606 | 0.9594 |
MDA-MB-231 | Vemurafenib | 0.12 | uM | LJP5 | 3 | C17 | 72 | hr | 1311 | 4820 | 5010 | 0.9619 | 0.9602 |
MDA-MB-231 | Vemurafenib | 0.37 | uM | LJP5 | 1 | C16 | 72 | hr | 1311 | 4761 | 5128 | 0.9284 | 0.9258 |
MDA-MB-231 | Vemurafenib | 0.37 | uM | LJP5 | 2 | C16 | 72 | hr | 1311 | 5260 | 5100 | 1.0314 | 1.0318 |
MDA-MB-231 | Vemurafenib | 0.37 | uM | LJP5 | 3 | C16 | 72 | hr | 1311 | 4451 | 5010 | 0.8883 | 0.8811 |
MDA-MB-231 | Vemurafenib | 1.11 | uM | LJP5 | 1 | C15 | 72 | hr | 1311 | 4870 | 5128 | 0.9496 | 0.9481 |
MDA-MB-231 | Vemurafenib | 1.11 | uM | LJP5 | 2 | C15 | 72 | hr | 1311 | 4742 | 5100 | 0.9298 | 0.9271 |
MDA-MB-231 | Vemurafenib | 1.11 | uM | LJP5 | 3 | C15 | 72 | hr | 1311 | 4583 | 5010 | 0.9146 | 0.9098 |
MDA-MB-231 | Vemurafenib | 3.33 | uM | LJP5 | 1 | C14 | 72 | hr | 1311 | 4097 | 5128 | 0.7989 | 0.7843 |
MDA-MB-231 | Vemurafenib | 3.33 | uM | LJP5 | 2 | C14 | 72 | hr | 1311 | 4226 | 5100 | 0.8286 | 0.8170 |
MDA-MB-231 | Vemurafenib | 3.33 | uM | LJP5 | 3 | C14 | 72 | hr | 1311 | 3859 | 5010 | 0.7701 | 0.7473 |
MDA-MB-231 | Vemurafenib | 10 | uM | LJP5 | 1 | C13 | 72 | hr | 1311 | 2660 | 5128 | 0.5187 | 0.4325 |
MDA-MB-231 | Vemurafenib | 10 | uM | LJP5 | 2 | C13 | 72 | hr | 1311 | 2858 | 5100 | 0.5604 | 0.4882 |
MDA-MB-231 | Vemurafenib | 10 | uM | LJP5 | 3 | C13 | 72 | hr | 1311 | 2715 | 5010 | 0.5418 | 0.4568 |
MDA-MB-231 | Enzastaurin | 0.04 | uM | LJP5 | 1 | D18 | 72 | hr | 1311 | 4728 | 5128 | 0.9219 | 0.9190 |